Peter Courtney

@PeterCourtney2

Biotech, Pharma and Genomics (Banjo, Guitar and Lap Steel)

London
Joined September 2012

Tweets

You blocked @PeterCourtney2

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @PeterCourtney2

  1. Apr 29
  2. 24 Sep 2015

    responsible for changing the face of healthcare in the US. There are problems, but he is just the tip of the iceberg. 2/2

  3. 24 Sep 2015

    haven't tweeted in a while, but i just wanted to say that i'm enjoying the fact that the dbag that bio twitter used to laugh at seems to 1/2

  4. 25 Jun 2015

    Thankyou medical journalism for the comprehensive understanding of C-section autism risk you have given me.

  5. 30 Apr 2015
  6. Retweeted
    30 Mar 2015

    Visualing big data the way an artist would.

  7. 12 Aug 2014
  8. 25 Jul 2014
  9. 22 Jul 2014

    were the crenezumab subgroups (at least the stat sig one) prespecified? i've seen conflicting reports.

  10. 18 Jul 2014

    shares fell 3.6% to 1700p (!) when it was announced Flemming Ornskov was to take over as CEO.

  11. 16 Jul 2014

    Why no PR for crenez data? clearly material.

  12. 16 Jul 2014
  13. Retweeted
    26 Jun 2014
  14. 14 May 2014

    - they should spice this up by having Ian and Pascal take to the stand at the same time.

  15. 13 May 2014

    Soriot- Issue with takeover not the commitment but the disruption

  16. 13 May 2014
  17. 13 May 2014

    - Read being reprimanded for not answering questions. Admits R+D will be lower.

  18. 13 May 2014

    /$AZN: Ian Read is up.

  19. 12 May 2014

    Also NK-1 vs any old 5HT3 isn't exactly a fair contest for delayed CINV.

  20. Retweeted
    8 May 2014
    Replying to

    Finally both and the bapineuzumab consortium claimed evidence of target engagement in Ph3 studies.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·